Skip to main content

Mike Bates, Jim Richey, Kristen Anderson, Jim Parina, Donald Payne, Douglas Downing, Michael Mainelli, John Reed, Patrick Byrne, William Sullivan, John Ryder

Mike Bates, who was chief financial officer at Silicon Genetics through its sale to Agilent Technologies, has been named chief financial officer at St. Francis Medical Technologies of Alameda, Calif., a privately held company working on treatments for degenerative spinal disorders, the company said last week. Bates previously was at Penederm and Collagen Aesthetics.

Jim Richey joined Lumera of Seattle as senior advisor for business development, the company said last week. Richey has more than 25 years of experience in sales and marketing operations in the United States, Europe, and Japan.

He previously held senior executive positions at LJL BioSystems (acquired by Molecular Devices), PerSeptive BioSystems (acquired by Applied Biosystems, now Applera), Pharmacia Biosensor (now Biacore International), and Pharmacia Biotech (acquired by Amersham and then by General Electric), according to Lumera.

Kristen Anderson was named senior vice president of human resources for Abgenix, the company said recently. Previously, Anderson was vice president of human resources at Applied Biosystems. Before that, she was vice president for human resources and communication for the digital linear tape group at Quantum, Abgenix said.

Jim Parina joined Expression Analysis of Research Triangle Park, NC, as director of sales and business development, the company said recently. Parina previously was pharmaceutical business development manager for Applied Biosystems, and before that, worked in sales for PerkinElmer.

Donald Payne, previously a research scientist with Becton Dickinson, has joined Oryxe Energy International as executive vice president of research and intellectual property. Previously, Payne served as patent agent for the law firms of Fulbright & Jaworski; and Wildman, Harrold, Allen and Dixon.

Douglas Downing has been promoted to vice president of operations for Biolase of San Clemente, Calif., the company said recently. Downing, who joined the company in May, has been serving as the director of global operations. Prior to that, he was director of manufacturing for Becton Dickinson’s bioscience division. Previously, he was director of manufacturing for Coherent Medical Group, the company said.

Michael Mainelli, formerly an executive in the magnetic resonance imaging unit of GE Medical Systems, now GE Healthcare, has joined Intermagnetics General as president of its Invivo Corp. subsidiary, which makes superconducting materials for the medical, instrumentation, and energy markets.

John Reed, Burnham Institute president and CEO, and a director of Stratagene, has been named as a director of California’s new stem cell program.

Patrick Byrne was named senior vice president and president of the electronic products and solutions group of Agilent Technologies. He was hired to fill the position that will be vacated by William Sullivan, who was named president and CEO of the company, effective March 1, according to Agilent.

Skyscape of Hudson, Mass., has named John Ryder as vice president of sales. Ryder previously was vice president of sales and marketing for Advanced Instruments. He has also held sales positions at Baxter Healthcare, Curtin Matheson Scientific, and Becton Dickinson, Skyscape said.

The Scan

UK Funds to Stay Ahead of Variants

The UK has announced a further £29.3 million to stay on top of SARS-CoV-2 variants, the Guardian reports.

Push for Access

In a letter, researchers in India seek easier access to COVID-19 data, Science reports.

Not as Cold

Late-stage trial results are expected soon for an RNA-based vaccine that could help meet global demand as it does not require very cold storage, the New York Times writes.

Genome Research Papers on Microbes' Effects on Host Transfer RNA, Honeybee Evolution, Single-Cell Histones

In Genome Research this week: influence of microbes on transfer RNA patterns, evolutionary relationships of honeybees, and more.